Preprint · 2024 · Open access

AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review

Kaavya Kabilan

ScienceOpen · Published 26 December 2024 · DOI 10.14293/pr2199.001372.v1

Free PDFView at the publisherCite this paper

In brief

“AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review” is a 2024 preprint by Kaavya Kabilan, published in ScienceOpen. OpenAlex counts 1 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read.

Citations
1
Most cited in
2025 (1)
Authors
1

Abstract

Artificial Intelligence (AI) is playing a transformative role in drug development, offering significant potential to accelerate the traditionally slow and expensive process. This review examines the integration of AI into key stages of drug discovery, such as target identification, compound screening, clinical trials, and personalized medicine. By reviewing recent advancements, the review highlights the strengths of AI in speeding up drug development, while also addressing the challenges such as data quality, model interpretability, and regulatory issues that still need to be overcome.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kabilan, K. (2024). AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review. ScienceOpen. https://doi.org/10.14293/pr2199.001372.v1

MLA 9

Kabilan, Kaavya. “AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review.” ScienceOpen, 2024. https://doi.org/10.14293/pr2199.001372.v1.

Chicago

Kabilan, Kaavya. 2024. “AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review.” ScienceOpen. https://doi.org/10.14293/pr2199.001372.v1.

Harvard

Kabilan, K. (2024) ‘AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review’, ScienceOpen. doi:10.14293/pr2199.001372.v1.

IEEE

K. Kabilan, “AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review,” ScienceOpen, 2024, doi: 10.14293/pr2199.001372.v1.

BibTeX

@misc{kabilan2024drug,
  title     = {{AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review}},
  author    = {Kabilan, Kaavya},
  howpublished = {ScienceOpen},
  year      = {2024},
  doi       = {10.14293/pr2199.001372.v1},
  url       = {https://doi.org/10.14293/pr2199.001372.v1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence
  • drug development
  • drug discovery
  • target identification
  • compound screening
  • clinical trials
  • personalized medicine
  • data quality

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Kabilan, K. (2024). AI in Drug Development: Speeding Up the Search for New Medicines – A Comprehensive Review. ScienceOpen. https://doi.org/10.14293/pr2199.001372.v1

How many times has this paper been cited?

1 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text.

Who wrote this paper?

Kaavya Kabilan.

What is the DOI of this paper?

10.14293/pr2199.001372.v1. The permanent link is https://doi.org/10.14293/pr2199.001372.v1.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.